Works matching IS 02692813 AND DT 2023 AND VI 57 AND IP 3
Results: 17
Editorial: predictors of disease activity during pregnancy in women with inflammatory bowel disease – a Danish cohort study. Authors' reply.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
Review article: diagnosis, pathophysiology and management of atrial fibrillation in cirrhosis and portal hypertension.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 3, p. 290, doi. 10.1111/apt.17368
- By:
- Publication type:
- Article
Editorial: predictors of disease activity during pregnancy in women with inflammatory bowel disease—a Danish cohort study.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
A practical use of noninvasive tests in clinical practice to identify high‐risk patients with nonalcoholic steatohepatitis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 3, p. 304, doi. 10.1111/apt.17346
- By:
- Publication type:
- Article
Letter: rising incidence and poor survival in patients with non‐viral HCC – better HCC surveillance and treatment for alcohol‐associated and non‐alcohol fatty liver diseases are needed. Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 3, p. 363, doi. 10.1111/apt.17361
- By:
- Publication type:
- Article
Factors associated with lower disease‐specific and generic health‐related quality of life in Rome IV irritable bowel syndrome.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 3, p. 323, doi. 10.1111/apt.17356
- By:
- Publication type:
- Article
Letter: chronic HDV infection—is ignorance bliss? Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 3, p. 359, doi. 10.1111/apt.17355
- By:
- Publication type:
- Article
Editorial: bacterial gut symbionts as live biotherapeutic agents in IBS—a rosy future despite potential long‐term safety concerns. Authorsʼ reply.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
Systematic review: the role of frailty in advanced chronic liver disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 3, p. 280, doi. 10.1111/apt.17324
- By:
- Publication type:
- Article
Prevalence and prognostic significance of vitamin C deficiency in patients with acute upper gastrointestinal bleeding: a prospective cohort study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 3, p. 313, doi. 10.1111/apt.17359
- By:
- Publication type:
- Article
Letter: ozanimod and latent tuberculosis—authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 3, p. 355, doi. 10.1111/apt.17345
- By:
- Publication type:
- Article
Letter: rising incidence and poor survival in patients with nonviral HCC—better HCC surveillance and treatment for alcohol‐associated and non‐alcohol fatty liver diseases are needed.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 3, p. 361, doi. 10.1111/apt.17334
- By:
- Publication type:
- Article
Editorial: bacterial gut symbionts as live biotherapeutic agents in irritable bowel syndrome—a rosy future despite potential long‐term safety concerns.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
Predictors of disease activity during pregnancy in women with inflammatory bowel disease—a Danish cohort study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 3, p. 335, doi. 10.1111/apt.17348
- By:
- Publication type:
- Article
Letter: Ozanimod and latent tuberculosis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 3, p. 353, doi. 10.1111/apt.17311
- By:
- Publication type:
- Article
Letter: chronic HDV infection—Is ignorance bliss?
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 3, p. 357, doi. 10.1111/apt.17291
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 3, p. 277, doi. 10.1111/apt.16995
- Publication type:
- Article